| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 10/01/2008 | CN101277709A A medical composition for treating wounds |
| 10/01/2008 | CN101277690A Abnormal protein removing composition |
| 10/01/2008 | CN101277687A Therapeutic agent for liver disease containing 2-amino-1,3-propanediol derivative as active ingredient and therapeutic method for liver disease |
| 10/01/2008 | CN101275109A Formula of physical-fatigue-relieving health wine and preparation thereof |
| 10/01/2008 | CN101274960A Genes associated with leishmania parasite virulence |
| 10/01/2008 | CN101274929A Thrombin receptor antagonists |
| 10/01/2008 | CN101274070A Compound formulation of capsules for curing dizziness and night sweat and preparing process |
| 10/01/2008 | CN101273988A Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles |
| 10/01/2008 | CN100422737C Preparation method of 'Xue Fu Zhu Yu' capsule and quality standard thereof |
| 10/01/2008 | CN100422341C Methods of quantitative detection of genetic recombinants and standard molecules for the methods |
| 10/01/2008 | CN100422335C Sequence regulating anther-specific expression of gene and its use in production of androsterile plants and hybrid seeds |
| 10/01/2008 | CN100422332C Expression and export of angiostation and endostatin as immunofusins |
| 10/01/2008 | CN100422322C Foot and mouth disease virus vaccine |
| 10/01/2008 | CN100422212C Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 10/01/2008 | CN100422185C Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications |
| 10/01/2008 | CN100422180C Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
| 10/01/2008 | CN100422164C Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 10/01/2008 | CN100422161C Hydroxymorpholinone derivative and medicinal use thereof |
| 10/01/2008 | CN100422155C Therapeutic agent for chronic obstructive pulmonary disease and method for treatment for chronic obstructive pulmonary disease with the same |
| 10/01/2008 | CN100421732C Plaster for the treatment of dysfunctions and disorders of nails |
| 10/01/2008 | CN100421731C Injection liquid of human autogenous collagen living cell and preparation method thereof |
| 10/01/2008 | CN100421680C Extractive of ginkgo tree leaves, prepn. method and application thereof |
| 10/01/2008 | CN100421677C Use of stub-like bacillus prepn. or acellular stub-like bacillus prepn. |
| 10/01/2008 | CN100421667C Method for treating and preventing hyperparathyroidism |
| 10/01/2008 | CN100421665C Mitotic kinesin inhibitors |
| 10/01/2008 | CN100421663C Imidazo (4,3-e)-1,2,4-triazolo(1,5-c) pyrimidines as adenosine A2A receptor antagonists |
| 10/01/2008 | CN100421661C Method of inducing cancer cell death and tumor regression |
| 10/01/2008 | CN100421651C Schisantherin A dispersible tablet and preparation process thereof |
| 09/30/2008 | US7429677 3'-methylene-bis(6-((4-methylphenyl)sulfonylamino)-benzoic acid) , or its N-oxide form, salt, stereoisomeric form, racemic mixture, prodrug or ester; block HIV from entering the human cell by interfering with various phases of attachment and fusion between HIV and the cell; Anti HIV agent; AIDS |
| 09/30/2008 | US7429648 IREN protein, its preparation and use |
| 09/30/2008 | US7429618 substituted triarylmethane compounds for immunosuppressive treatment of autoimmune disorders or inflammatory diseases; [Tris-(4-fluoro-phenyl)-methyl]-phosphonic acid dimethyl ester; Gardos channel antagonists |
| 09/30/2008 | US7429614 Medicament containing an effector of the glutathione metabolism together with α-lipoic acid for treating diabetes mellitus |
| 09/30/2008 | US7429612 Indoline compound and medicinal use thereof |
| 09/30/2008 | US7429609 Pyrazole compound and medicinal composition containing the same |
| 09/30/2008 | US7429607 5-HT2B receptor antagonists |
| 09/30/2008 | US7429602 Treating conjunctivitis by topically administering an epinastine solution to the conjunctiva |
| 09/30/2008 | US7429591 Inhibiting the proteolytic activity of cathepsin S; 1-[4-(2-Amino-6-chloro-phenyl)-piperazin-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma |
| 09/30/2008 | US7429587 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina |
| 09/30/2008 | US7429586 Non-imidazole aryloxyalkylamines |
| 09/30/2008 | US7429579 antagonism/inhibition, of the D3 receptor; substance abuse. |
| 09/30/2008 | US7429578 e.g. phenyl-3,4-dihydropyrrolo[4,3,2-de]isoquinolin-5-(1H)-one; anticarcinogenic agent; stroke, head trauma, and neurodegenerative disease; potentiating cytotoxicity of a DNA-damaging cytotoxic agent or ionizing radiation |
| 09/30/2008 | US7429568 Antidiabetic agents; human SGLT2 (sodium ion / glucose cotransporter 2) inhibitors; hyperglycemia, obesity; 3-(6-O-ethoxycarbonyl- beta -D-glucopyranosyloxy)-4-[(4-isopropoxyphenyl)methyl]-1-isopropyl-5-methylpyrazole |
| 09/30/2008 | US7429564 Orally administering insulin and delivery agent 4-[(4-chloro, 2-hydroxybenzoyl)amino]butanoic acid that facilitates the absorption of insulin from the gastrointestinal tract; diabetes mellitus; bioavailability comparable to injection; treating diabetes without the drawbacks of systemic hyperglycemia |
| 09/30/2008 | US7429561 Method for stimulating cell growth using sponge protein hydrolysates |
| 09/30/2008 | US7429559 Controlled release composition and method of producing the same |
| 09/30/2008 | US7429474 2-O sulfatase compositions and methods of analyzing therewith |
| 09/30/2008 | US7429449 Potassium channel mutants of the yeast Saccharomyces cerevisiae and their use for screening eukaryotic potassium channels |
| 09/30/2008 | CA2377762C Sulfonamidomethyl phosphonate inhibitors of .beta.-lactamase |
| 09/30/2008 | CA2355470C Benzoheterocycles and their use as mek inhibitors |
| 09/30/2008 | CA2323363C Novel compositions of eprosartan |
| 09/30/2008 | CA2314009C Triazole and imidazole derivatives |
| 09/30/2008 | CA2303848C Substituted anilides |
| 09/30/2008 | CA2285573C A method for stimulating red blood cell production |
| 09/30/2008 | CA2214219C Pyrido[2,3-d]pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation |
| 09/30/2008 | CA2195856C Substituted o6-benzylguanines and use thereof |
| 09/30/2008 | CA2183050C Sulfonyl- or sulfinylbenzoylguanidine derivatives |
| 09/25/2008 | WO2008115061A2 Dual targeting system |
| 09/25/2008 | WO2008114857A1 Method for producing aminoacetylpyrrolidinecarbonitrile derivative |
| 09/25/2008 | WO2008114819A1 Novel adenine compound |
| 09/25/2008 | WO2008114817A1 Novel adenine compound |
| 09/25/2008 | WO2008114812A1 Jak inhibitor |
| 09/25/2008 | WO2008114732A1 Wrinkling-preventing and -modifying agent |
| 09/25/2008 | WO2008114660A1 Composition having antioxidant activity |
| 09/25/2008 | WO2008114536A1 Dehydroepiandrosterone production promoter and use thereof |
| 09/25/2008 | WO2008114516A1 Liposome and immunostimulating composition comprising the same |
| 09/25/2008 | WO2008114505A1 Eg5 inhibitor and agent for treatment of cell proliferative disease containing the same |
| 09/25/2008 | WO2008114488A1 Therapeutic agent for autoimmune skin disease containing polypeptide as active ingredient |
| 09/25/2008 | WO2008080128B1 Devices and methods for inhibiting fibrosis |
| 09/25/2008 | WO2007042272A3 Use of a nutraceutical composition comprising resveratrol for the treatment of age-related diseases |
| 09/25/2008 | US20080234471 Dna sequence; open-reading frame; genetic engineering |
| 09/25/2008 | US20080234375 Process for Decreasing Environmental Pollutants in an Oil or a Fat, a Volatile Environmental Pollutants Decreasing Working Fluid, a Health Supplement, and an Animal Feed Product |
| 09/25/2008 | US20080234358 E-series of prostaglandin (EP) receptors; [[4-(4,9-dipropoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl) phenyl]acetic acid |
| 09/25/2008 | US20080234346 Pyrazalidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 09/25/2008 | US20080234327 2-(benzo[d]thiazol-2-yl)-4,5-dihydro-2H-benzo[e]indazol-1-ol; hereditary hemochromatosis, anemias |
| 09/25/2008 | US20080234320 Curcumin analogs with anti-tumor and anti-angiogenic properties |
| 09/25/2008 | US20080234310 Administering cis(+-) 2,8-dimethyl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole; prolonging lifespan, improving quality of life |
| 09/25/2008 | US20080234304 N3-Pyridyl-Thiamine And Its Use In Cancer Treatments |
| 09/25/2008 | US20080234296 Triazolo[4,5-d] pyramidine derivatives and their use as purinergic receptor antagonists |
| 09/25/2008 | US20080234278 Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions |
| 09/25/2008 | US20080234274 Novel Compounds |
| 09/25/2008 | US20080234241 Melanogenesis inhibitors and whitening agents comprising ergosterol derivative and compositions containing ergosterol derivative |
| 09/25/2008 | US20080234230 Pharmaceutical Composition for Regulation of Pancreatic Juice Secretion Comprising a LPA Receptor Modulator |
| 09/25/2008 | US20080234217 Double stranded nucleotide sequences for use as tools in tissue targeted gene expression inhibition and treatment of cancer, vascular, neuronal and endocrine diseases |
| 09/25/2008 | US20080234216 TGF-beta type receptor cDNAs encoded products and uses therefor |
| 09/25/2008 | US20080234213 Oncogenic regulatory RNAs for diagnostics and therapeutics |
| 09/25/2008 | US20080234201 BH3 peptides and method of use thereof |
| 09/25/2008 | US20080234187 In particular amidated, acetylated, phosphorylated and/or glycosylated derivatives; diagnostic agents including a nucleic acid or messenger RNA coding for the cytokine; isolated from human hemofiltrate |
| 09/25/2008 | US20080234186 Synthetic, for the enhancement of fertility, egg production and/or spermatogenesis |
| 09/25/2008 | US20080234184 These membrane domains are of viral envelope proteins that allow viruses to anchor to the target cells that they will infect; allows coexpression of the TME1 and TME2 membrane domains of the hepatitis C virus envelope proteins |
| 09/25/2008 | US20080234181 Antisense Epidermal Growth Factor Receptor/oligonucleotides in which guanidinium residue substitution (N-(2-aminoethyl) D-arginine) is distributed throughout the oligonucleotide; excellent uptake into mammalian cells; resists nucleases and proteases both outside and inside the cell(s) |
| 09/25/2008 | US20080234177 Targeting-enhanced activation of galectins |
| 09/25/2008 | US20080233646 Human DR4 antibodies and uses thereof |
| 09/25/2008 | US20080233556 Cytotonic protein and utlization thereof |
| 09/25/2008 | US20080233213 Hair sustaining formulation |
| 09/25/2008 | US20080233197 Pharmaceutical compositions |
| 09/25/2008 | US20080233190 Segmented Pharmaceutical Dosage Forms |
| 09/25/2008 | US20080233174 Polymer and an active ingredient; polyethylene oxide, polyvinyl acetate, polymethacrylate, polyethylene glycols, polypropylene glycol, polyethylene/polypropylene glycol copolymer or polyvinylpyrolindone and dextromethorphan, acetaminophen, or simethicone |
| 09/25/2008 | US20080233162 Bio-degradable aliphatic polyesters, polylactic acid, polyglycolic acid, poly(D,L-lactide-co-glycolide), poly(caprolactone), polyester-amide/polyester-urethane, poly(valerolactone), poly(hydroxyl butyrate) a poly(hydroxyl valerate) or chitosan, chitin, alginic acid, collagen, gelatin or hyaluronic acid |
| 09/25/2008 | US20080233158 Two-coat makeup product, its uses, and makeup kit comprising the product |
| 09/25/2008 | US20080233126 G Proteins, Polynucleotides Encoding the Same and Utilization Thereof |